Merck KGaA Cancer Vaccine Studies On Clinical Hold Because Of Encephalitis, But AE Isn't In Lead Indications
This article was originally published in The Pink Sheet Daily
Executive Summary
The single event occurred in an exploratory study with a very different patient population and regimen than Phase III trials of the vaccine against lung and breast cancers, leaving hope the setback will be short-lived.